论文部分内容阅读
Objective:We aimed to evaluate the feasibility and effectiveness of postoperative 125I brachytherapy delivered by use of digital model obturators for recurrent or locally advanced maxillary cancers.Materials and Methods:From 2006 to 2008,12 patients(7 females; median age 65 years [range 22-86 years])with recurrent or locally advanced maxillary cancers showing positive margins after surgery underwent 125I brachytherapy by use of digital model obturators and interstitial implants.The radioactivity was 18.5-33.3 MBq per seed and the prescription dose 80-160 Gy.Functional outcome of patients was evaluated by the Performance Status Scale(PSS)for head and neck cancer before and after brachytherapy.